Searched for
K NITHYANANDA REDDY
Aurobindo Pharma Q1 results: Net profit jumps 61% at Rs 919 croreRevenue from operations increased to Rs 7,567 crore in the June quarter as against Rs 6,851 crore in the year-ago period, the drug maker sa...- Aurobindo Pharma Q1 profit up 10 pc at Rs 571 crWith the product pipeline continuing to advance, and execution of growth drivers proceeding as planned, the company is confident that its f...
- Buy Aurobindo Pharma, target price Rs 763: ICICI DirectAurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 44792.08 Crore) operating in Pharmaceuti...
- Sell Aurobindo Pharma, target price Rs 597.5: ICICI DirectAurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 35144.60 Crore) operating in Pharmaceuti...
- Buy Aurobindo Pharma, target price Rs 538: Nuvama WealthBreakout above its falling 200 DMA after a gap oftwo years adding to the bullish conviction.
- Buy Aurobindo Pharma, target price Rs 564: BNP Paribas SecuritiesPromoters held 51.83 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.43 per cent, DIIs 16.55 per cent.
- Aurobindo Pharma Q2 results: Net profit drops 41% to Rs 409 croreAurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company's second quarter performance was subdued, mainly ...
- Aurobindo Pharma names K Nithyananda Reddy as managing director"Mr. Reddy has been a key member of Aurobindo leadership and has played a pivotal role in the Company’s growth journey since inception. A v...
- Edelweiss Securities maintains ‘hold’ on Aurobindo Pharma, target price Rs 535The brokerage believes earnings growth beyond FY21 would remain challenging given limited growth drivers and doubling of R&D.
- Buy Aurobindo Pharma, target price Rs 430: Kunal BothraKunal Bothra recommended to keep stoploss at Rs 398.
- Buy Aurobindo Pharma, target Rs 820: Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 820 and a stoploss at Rs 770 from entry point.
- Buy Aurobindo Pharma, target Rs 805: Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 805.0 and a stoploss at Rs 765 from entry point.
- Buy Aurobindo Pharma, target Rs 750: Dr CK NarayanBuy Aurobindo Pharma Ltd. at a price target of Rs 750.0 and a stoploss at Rs 725 from entry point.
- Buy Aurobindo Pharma, target Rs 825: Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 825.0 and a stoploss at Rs 775 from entry point.
- Buy Aurobindo Pharma, target Rs 630: Dr CK NarayanBuy Aurobindo Pharma Ltd. at a price target of Rs 630.0 and a stop loss at Rs 610 from the entry point.
- Sell Aurobindo Pharma, target Rs 568: Dr CK NarayanSell Aurobindo Pharma Ltd. at a price target of Rs 568.0 and a stop loss at Rs 585 from entry point.
- Buy Aurobindo Pharma, target Rs 610: Manas JaiswalBuy Aurobindo Pharma Ltd. at a price target of Rs 610.0 and a stop loss at Rs 574 from entry point.
- Buy Aurobindo Pharma, target Rs 722: Kunal BothraBuy Aurobindo Pharma Ltd. at a price target of Rs 722.0 and a stoploss at Rs 668 from entry point.
- Buy Aurobindo Pharma, target Rs 850: Kunal BothraBuy Aurobindo Pharma at a price target of Rs 850 and a stop loss at Rs 750 from the entry point.
- Buy Aurobindo Pharma, target Rs 785: Shrikant ChouhanBuy Aurobindo Pharma at a price target of Rs 785 and a stop loss at Rs 732 from entry point.
Load More
